These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26200935)

  • 1. Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation.
    Alayev A; Berger SM; Holz MK
    Ann N Y Acad Sci; 2015 Aug; 1348(1):116-23. PubMed ID: 26200935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells.
    Alayev A; Sun Y; Snyder RB; Berger SM; Yu JJ; Holz MK
    Cell Cycle; 2014; 13(3):371-82. PubMed ID: 24304514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of combining rapamycin and resveratrol on apoptosis and growth of TSC2-deficient xenograft tumors.
    Alayev A; Salamon RS; Sun Y; Schwartz NS; Li C; Yu JJ; Holz MK
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):637-46. PubMed ID: 25844891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting mTOR: evaluating the therapeutic potential of resveratrol for cancer treatment.
    Wu Y; Liu F
    Anticancer Agents Med Chem; 2013 Sep; 13(7):1032-8. PubMed ID: 23272906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells.
    Alayev A; Berger SM; Kramer MY; Schwartz NS; Holz MK
    J Cell Biochem; 2015 Mar; 116(3):450-7. PubMed ID: 25336146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade.
    Rivera Rivera A; Castillo-Pichardo L; Gerena Y; Dharmawardhane S
    PLoS One; 2016; 11(6):e0157251. PubMed ID: 27285995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol directly targets DDX5 resulting in suppression of the mTORC1 pathway in prostate cancer.
    Taniguchi T; Iizumi Y; Watanabe M; Masuda M; Morita M; Aono Y; Toriyama S; Oishi M; Goi W; Sakai T
    Cell Death Dis; 2016 May; 7(5):e2211. PubMed ID: 27148684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of Rapamycin and Resveratrol for Treatment of Bladder Cancer.
    Alayev A; Salamon RS; Schwartz NS; Berman AY; Wiener SL; Holz MK
    J Cell Physiol; 2017 Feb; 232(2):436-446. PubMed ID: 27225870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition.
    Park D; Jeong H; Lee MN; Koh A; Kwon O; Yang YR; Noh J; Suh PG; Park H; Ryu SH
    Sci Rep; 2016 Feb; 6():21772. PubMed ID: 26902888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
    Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
    Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tumor cell growth, proliferation and migration by X-387, a novel active-site inhibitor of mTOR.
    Chen SM; Liu JL; Wang X; Liang C; Ding J; Meng LH
    Biochem Pharmacol; 2012 May; 83(9):1183-94. PubMed ID: 22305748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anticancer effects of curcumin via targeting the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway.
    Tamaddoni A; Mohammadi E; Sedaghat F; Qujeq D; As'Habi A
    Pharmacol Res; 2020 Jun; 156():104798. PubMed ID: 32278045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling.
    van Veelen W; Korsse SE; van de Laar L; Peppelenbosch MP
    Oncogene; 2011 May; 30(20):2289-303. PubMed ID: 21258412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR: more targets of resveratrol?
    Widlund AL; Baur JA; Vang O
    Expert Rev Mol Med; 2013 Sep; 15():e10. PubMed ID: 24060150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol inhibits glucose metabolism in human ovarian cancer cells.
    Kueck A; Opipari AW; Griffith KA; Tan L; Choi M; Huang J; Wahl H; Liu JR
    Gynecol Oncol; 2007 Dec; 107(3):450-7. PubMed ID: 17825886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prosurvival role of autophagy in resveratrol-induced cytotoxicity in GH3 cells.
    Zhang X; Xu W; Su J; Chu M; Jin H; Li G; Tan C; Wang X; Wang C
    Int J Mol Med; 2014 Apr; 33(4):987-93. PubMed ID: 24534837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.
    Polivka J; Janku F
    Pharmacol Ther; 2014 May; 142(2):164-75. PubMed ID: 24333502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [mTOR inhibitor].
    Muro K
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):7-11. PubMed ID: 21368454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway.
    Kanamori H; Takemura G; Goto K; Tsujimoto A; Ogino A; Takeyama T; Kawaguchi T; Watanabe T; Morishita K; Kawasaki M; Mikami A; Fujiwara T; Fujiwara H; Seishima M; Minatoguchi S
    Am J Pathol; 2013 Mar; 182(3):701-13. PubMed ID: 23274061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.
    Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS
    Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.